Get Full Government Meeting Transcripts, Videos, & Alerts Forever!
Get email alerts on the Opioid Litigation Settlement topic
No spam. Unsubscribe anytime.
City Council authorizes participation in Purdue Chapter 11 plan and related pharmaceutical settlements
Summary
After moving into executive session, the council unanimously approved a resolution authorizing city legal counsel to accept and participate in the thirteenth amended joint Chapter 11 plan in Purdue Pharma’s bankruptcy and to join related governmental and manufacturer settlement agreements involving multiple pharmaceutical companies.
The Oklahoma City Council voted unanimously to authorize the city’s legal counsel to accept and participate in the thirteenth amended joint Chapter 11 plan for Purdue Pharma and to join governmental‑entity settlement agreements and related manufacturer settlements, the council recorded after holding an executive session.
The council’s resolution authorized four related actions: authorizing the city’s legal counsel to cast the city’s ballot in favor of the amended joint Chapter 11 plan in the Purdue bankruptcy case; approving the city’s participation in a governmental‑entity settlement agreement dated June 17, 2025; authorizing participation agreements with several generic and secondary manufacturers named in the transcript; and authorizing litigation counsel to negotiate and enter a state subdivision agreement with the Oklahoma attorney general for the generic/secondary manufacturer settlement.
The transcript lists the manufacturers and entities named in the motion, including Alvogen, Amneal, Apotex, Hikma, Indivior, Mylan, Sun Pharmaceutical Industries and Zydus (among others), and cites participation in settlements with those companies as part of the request to the council. The resolution also referenced the thirteenth amended joint Chapter 11 plan in the Purdue proceedings pending in the United States Bankruptcy Court for the Southern District of New York (Case No. 19‑23649).
The council moved into executive session to receive an attorney update and then returned to vote; the motion passed unanimously. The transcript does not record a named mover or seconder for the final vote in open session.
